The largest database of trusted experimental protocols

Alk detection kit

Manufactured by Nichirei Biosciences
Sourced in Japan

The ALK Detection Kit is a laboratory tool used to detect the presence of the anaplastic lymphoma kinase (ALK) protein. It is designed to provide a reliable and efficient method for identifying ALK expression in various biological samples. The kit includes the necessary reagents and protocols to perform the ALK detection analysis.

Automatically generated - may contain errors

6 protocols using alk detection kit

1

Molecular Profiling of Lung Cancers

Check if the same lab product or an alternative is used in the 5 most similar protocols
EGFR and RAS gene mutations were analyzed in paraffin-embedded tissue sections from BM only. EGFR mutations (including G719X in exon 18, exon 19 deletion, T790M in exon 20, and L858R and L861Q in exon 21) and RAS mutations (G12C and G12A in exon 2 and Q61H in exon 3) were detected in matching formalin-fixed paraffin-embedded tissue samples using cycleave PCR (which was performed by SRL Inc., Tokyo, Japan, cobas® EGFR Mutation Test v2 kit and MEBGEN RASKET kit according to the manufacture's protocol). ALK rearrangement was analyzed by immunohistochemistry (ALK Detection kit; Nichirei Bioscience, Tokyo, Japan), according to the manufacturer's protocols. The slides were observed under ×200 magnification using a BX50 fluorescence microscope (Olympus Corporation, Tokyo, Japan).
+ Open protocol
+ Expand
2

Immunohistochemical Detection of EML4-ALK

Check if the same lab product or an alternative is used in the 5 most similar protocols
All Xuanwei samples were subjected to IHC to detect the EML4-ALK fusion protein. IHC was performed on 4-µm FFPE tissue sections placed on silane-coated slides using the 5A4 anti-ALK primary antibody in the ALK Detection kit (Nichirei Bioscience, Tokyo, Japan) (12 (link)). Tumor cells that stained more strongly in the cytoplasm compared with negative control cells, were defined as IHC-positive. Semi-quantitative assessment was performed by estimating the percentage of IHC-positive tumor cells. ALK IHC scores were assigned using the iAEP method (iScore) as follows: 0, no stained cells; 1, 0–50% stained tumor cells; 2, 50–80% stained tumor cells or >80% stained tumor cells with marked variability of staining intensity (‘checkerboard pattern’); and 3, >80% stained tumor cells without marked variability of staining intensity.
+ Open protocol
+ Expand
3

Immunohistochemical Evaluation of hNLRR1

Check if the same lab product or an alternative is used in the 5 most similar protocols
The six NB specimens were surgically collected and embedded in paraffin at Kyushu University Hospital. The appropriate informed consent was obtained under the institutional review board-approved protocol. The formalin-fixed, paraffin-embedded specimens and a purchased tissue array MC803a (U.S. Biomax) were deparaffinised and stained with an anti-hNLRR1 antibody (R&D, 1:250) overnight. The signal was detected by a biotin-conjugated secondary antibody and streptavidin-horseradish peroxidase (HRP) (VECTOR), followed by diaminobenzidine staining (VECTOR). An ALK detection kit (Nichirei) was used according to the manufacturer’s protocol. The study was approved by the Kyushu University of Medical Human Investigation Committee and the internal review board of the Chiba Cancer Center. The study was performed in accordance with the approved guideline.
+ Open protocol
+ Expand
4

Immunohistochemical Analysis of ALK

Check if the same lab product or an alternative is used in the 5 most similar protocols
Anti-ALK IHC was performed using the iAEP method (ALK Detection Kit, Nichirei Bioscience, Tokyo, Japan) with an automatic staining protocol13 (link),25 (link). To confirm ALK positivity, IHC (and/or FISH) was also performed and evaluated by a commercial clinical laboratory (SRL, Tokyo). ALK IHC results were classified using iScore for iAEP IHC14 (link),26 (link).
+ Open protocol
+ Expand
5

Post-alectinib treatment in ALK-rearranged NSCLC

Check if the same lab product or an alternative is used in the 5 most similar protocols
Patients with ALK-rearranged NSCLC who received LOR (LOR group [100 mg orally once daily]) or PEM (PEM group [500 mg/m2]: pemetrexed alone or combination with a platinum agent) as post-alectinib treatment between December 2012 and May 2020 at the National Cancer Center Hospital were included. The cutoff date for our analysis was March 30, 2021. Medical records, including patient characteristics and clinical outcomes, were retrospectively reviewed. The ALK gene rearrangement was identified by immunohistochemistry (ALK Detection Kit, Nichirei Bioscience, Tokyo, Japan; DF53, Roche, Basel, Switzerland; and 5A4, Abcam, Cambridge, United Kingdom), fluorescence in situ hybridization (Vysis ALK Break Apart FISH Probe Kit, Abbott Molecular, Abbott Park, IL), reverse-transcriptase polymerase chain reaction analysis, and next-generation sequencing (Oncomine Dx Target Test, Thermo Fisher Scientific, Waltham, MA).
+ Open protocol
+ Expand
6

Immunohistochemistry Analysis of ALK and P-gp

Check if the same lab product or an alternative is used in the 5 most similar protocols
Formalin-fixed, paraffin-embedded tissue specimens were sliced by a thickness of 4 μm, and the sections were placed on silane-coated slides. For antigen retrieval, slides were heated for 45 min at 105 °C in an antigen retrieval solution at pH 9.0 (Nichirei Biosciences, Inc., Tokyo, Japan). Antigen–antibody complexes were visualized with Histofine Simple Stain MAX PO detection reagent (Nichirei Biosciences, Inc.). The ALK Detection Kit (Nichirei Biosciences, Inc.), which is based on the intercalated antibody-enhanced polymer (iAEP) method (Takeuchi et al., 2009 (link)), was used for anti-ALK IHC analysis. The staining procedure was performed using the Histostainer automated staining system (Nichirei Biosciences, Inc.). For IHC of P-gp, anti-ABCB1 (P-gp) monoclonal antibody (6C4.2, Chemicon International Inc.) was used. Positivity for P-gp was standardized using KB3-1 (negative control) and ABCB1 overexpressed KB3-1 (KB3-1/ABCB1, positive control).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!